1.8mn doses of Sinovac Covid vaccine arrive in Indonesia
- by Joy Garcia
- in Medicine
- — Jan 3, 2021
COVAX was created by several organizations including GAVI, CEPI, and WHO with an aim of accelerating the development and manufacture of COVID-19 vaccines, and guarantee fair and equitable access for every country in the world.
Chinese Ambassador to Egypt Liao Liqiang (L), Egyptian Health Minister Hala Zayed (C) and Egyptian Assistant Minister of Health for Public Health Initiatives Mohamed Hassani attend the signing ceremony of the letter of intent on COVID-19 vaccine cooperation between China and Egypt in Cairo, Egypt, on December 31, 2020.
China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate to state-backed Sinopharm, after the developer said the vaccine showed 79.34% efficacy based on an interim analysis of late-stage clinical trials.
Almost 2.8 million people in the USA have received the first vaccine of a two-dose regimen, according to figures from the Centers for Disease Control and Prevention, though officials have said there are lags in reporting that data.
The minister told Reuters the purchase would be of the vaccine candidate developed by Sinopharm's Beijing Institute of Biological Products.
Cosnumers worldwide spent a record $407.6 million on apps
In the United States , mobile games generated the most revenue of $87.2 million, up 26.4 percent from almost $69 million in 2019. As always, although there are more Android devices than iOS, it was the iOS apps that generated the most revenue by far.
As part of the arrangements for carrying out the vaccine trial in the province, the health department has made arrangements for setting up a vaccination facility at the Expo Centre in Karachi, where 5,000 persons will be administered vaccine doses daily.
ONCE again, China has proved its credentials as a trusted global power by expressing its commitment to share Covid-19 vaccine with other members of the worldwide community in a fairer and transparent manner.
Hassan Abbas of AJ Pharma, CanSino's local representative, has said that recruitment for the trial will be completed in 10 days. He also assured that China will give priority to developing countries for vaccines and this will be done through a variety of ways, including through donations and aid.
AJ Pharma is one of five companies that have applied for a license to distribute the vaccine in Pakistan once approved, he added.
